INMACULADA
PÉREZ CAMACHO
PERSONAL INVESTIGADOR GARANTIA JUVENIL
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (9)
2024
-
A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study
Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 8, pp. 1794-1800
-
Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study
Clinical Microbiology and Infection, Vol. 30, Núm. 8, pp. 1035-1041
-
Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 2011-2022
-
Early Antibiotic De-escalation in Patients With Severe Infections Due to Bloodstream Infection by Enterobacterales: A Post Hoc Analysis of a Prospective Multicentre Cohort
International Journal of Antimicrobial Agents, Vol. 64, Núm. 5
-
Long or complicated mpox in patients with uncontrolled HIV infection
Journal of Medical Virology, Vol. 96, Núm. 3
-
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 9, pp. 2132-2141
-
Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study
The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399
2023
-
Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort
Antibiotics, Vol. 12, Núm. 1
-
Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial
Open Forum Infectious Diseases, Vol. 10, Núm. 4